Blend Labs, Inc. reports developments tied to its digital origination platform for banks, credit unions, fintechs, community banks, and independent mortgage lenders. The company’s platform supports mortgage, home equity, consumer-loan, and deposit-account workflows, connecting borrower experiences with lender back-end origination processes.
Recurring news for BLND includes quarterly financial results, customer additions and expansions, lender partnerships, product launches, and AI-enabled origination tools such as Blend Autopilot and Autopilot MCP. Company updates also cover capital actions involving its Class A common stock and operating changes related to efficiency, restructuring costs, and platform-focused strategy.
Blend Labs, Inc. (NYSE:BLND) announced its first quarter 2024 financial results, meeting revenue guidance and surpassing operating loss targets. The company welcomed new customers, expanded its product suite, and secured a $150 million investment from Haveli Investments. Blend retired its term loan, improving free cash flow and operating income. Revenue totaled $34.9 million, with a 52% GAAP gross profit margin. The company is on track to achieve non-GAAP profitability within the year.
Blend Labs, Inc. (NYSE: BLND) will announce its first quarter 2024 financial results on May 8, 2024. The company will host a conference call to discuss the results and provide accompanying financial information. Investors can access the press release and live discussion through the Company's investor website. A replay will be available after the discussion.
Blend Labs, Inc. (NYSE: BLND) announces a strategic partnership with Haveli Investments, involving a $150 million investment. Haveli purchased convertible preferred stock, with a zero percent coupon, to strengthen Blend's financial position and balance sheet. The investment will be used to repay existing credit and for general corporate purposes. Brian Sheth from Haveli will join Blend's Board. The partnership aims to drive innovation in financial services and deliver value for customers and shareholders.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.